Form 4: Abeona Therapeutics CFO Joseph Vazzano Reports Stock Disposal to Cover Tax Obligations
SEC Form 4 Filing
Joseph Vazzano, CFO of Abeona Therapeutics, disposed of 1,055 shares of common stock on July 21, 2024, to cover tax obligations related to vesting restricted stock.
Summary
- On July 21, 2024, Joseph Vazzano, the Chief Financial Officer of Abeona Therapeutics, disposed of 1,055 shares of common stock.
- The transaction was executed to satisfy tax withholding obligations upon the vesting of restricted stock.
- The shares were disposed of at a price of $5.11 per share.
- Following the transaction, Vazzano directly owns 371,605 shares of Abeona Therapeutics common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, so it doesn't necessarily indicate positive or negative sentiment towards the company's prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders, like the CFO, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a small percentage of the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 07/21/2024 | Date of stock disposal transaction |
| 07/22/2024 | Date of signature on the Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.